Results 61 to 70 of about 2,997 (148)

Intraoperative Use of Vasoactive Agents in Non‐Cardiac Surgery: Protocol for a Post Hoc Cohort Study

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 2, February 2026.
ABSTRACT Background Intraoperative hypotension is a well‐known clinical condition and often treated with vasoactive agents. Previous cohort studies have indicated that large numbers of patients receive this treatment, but they have been limited to specific surgical populations or single agents.
Emilie Stokholm Bækgaard, Morten Vester‐Andersen, Anders Granholm, Morten Hylander Møller, Ben Creagh‐Brown, Ib Jammer, Mette Krag   +6 more
wiley   +1 more source

Clinical benefit of fixed-dose dual bronchodilation with glycopyrronium and indacaterol once daily in patients with chronic obstructive pulmonary disease: a systematic review

International Journal of COPD, 2014
Charlotte Suppli UlrikDepartment of Respiratory Medicine, Hvidovre Hospital and University of Copenhagen, Hvidovre, DenmarkBackground and aim: Long-acting bronchodilators are the preferred option for maintenance therapy of patients with chronic ...
Ulrik CS
doaj  

Six‐Year Trends in Real‐World Data Use for Post‐Marketing Surveillance of New Medical Products in Japan

Clinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT The Ministerial Ordinance on Good Post‐Marketing Study Practice for Drugs was amended by the Ministry of Health, Labour and Welfare (MHLW) in 2018 to clearly define post‐marketing database studies (DBS) as a measure of pharmacovigilance activities for approved medical products in Japan.
Suguru Okami, Kako Shimotsumagari, Yasunari Sadatsuki   +2 more
wiley   +1 more source

Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD

International Journal of COPD, 2018
Gary T Ferguson,1 Roberto Rodriguez-Roisin,2 Colin Reisner,3,4 Andrea Maes,3 Shahid Siddiqui,4 Ubaldo J Martin4 1Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA; 2Universitat de Barcelona, Hospital Clínic-The August ...
Ferguson GT, Rodriguez-Roisin R, Reisner C, Maes A, Siddiqui S, Martin UJ   +5 more
doaj  

Clozapine‐Associated Pulmonary Embolism: Continuation of Clozapine Therapy With Concurrent Anticoagulation

Case Reports in Psychiatry, Volume 2026, Issue 1, 2026.
Clozapine, a gold standard for treatment‐resistant schizophrenia, is associated with a range of adverse effects, including the rare but serious risk of pulmonary embolism (PE). The management of such complications, particularly in the absence of clear guidelines for preventive anticoagulation, poses significant challenges.
M. R. Jahangir, C. Heerema, J. Biedermann, S. Dieleman, N. H. Grootendorst-van Mil, Philipp Sand   +5 more
wiley   +1 more source

Effects of Tezepelumab in “United Airway Disease” (Asthma and CRSwNP)

Case Reports in Pulmonology, Volume 2026, Issue 1, 2026.
Severe asthma is a heterogeneous disease typically characterized by inadequate symptom control, even with frequent oral corticosteroids, large doses of inhaled corticosteroids, and long‐acting β2‐adrenergic agonists. The latest Global Initiative for Asthma (GINA) recommendations suggest adding biological therapies at Step 5 to optimize standard ...
Chiara Lupia, Giovanna Lucia Piazzetta, Daniela Pastore, Nadia Lobello, Mariaimmacolata Preianò, Emanuela Chiarella, Angelantonio Maglio, Alessandro Vatrella, Girolamo Pelaia, Corrado Pelaia, Nidhi Chaudhary   +10 more
wiley   +1 more source

A Novel Stability-Indicating Method for Simultaneous Estimation of Glycopyrronium Bromide and Neostigmine Methyl Sulfate Injectable Formulations by RP-HPLC

Indonesian Journal of Chemistry
Glycopyrronium bromide and neostigmine methyl sulfate drugs combination is used in treatment as an injectable formulation. The present study proposes the development and validation of an accurate, selective, and sensitive RP-HPLC method, which will ...
Chetankumar Mashru, Jayesh Dhalani
doaj   +1 more source

Determination of the pharmacokinetics of glycopyrronium in the lung using a population pharmacokinetic modeling approach

, 2013
BACKGROUND Glycopyrronium bromide (NVA237) is a once-daily long-acting muscarinic antagonist recently approved for the treatment of chronic obstructive pulmonary disease (COPD).
Kaiser, Guenther, Sechaud, Romain, Bartels, Christian, Looby, Michael   +3 more
core   +1 more source

Comparative effectiveness of indacaterol/glycopyrronium in the treatment of chronic obstructive pulmonary disease

, 2017
Indacaterol/glycopyrronium has been the first long-acting β2-agonist (LABA)/long-acting muscarinic antagonist (LAMA) fixed-dose combination to be approved as a maintenance treatment in chronic obstructive pulmonary disease patients.
Paola Rogliani, Mario Cazzola, Rogliani, P, Cazzola, M, Rogliani P., Cazzola M.   +5 more
core   +1 more source

Aquagenic palmoplantar keratoderma therapeutic response to topical glycopyrronium

JAAD Case Reports, 2021
Emily J. Medhus, BS, Ansley C. DeVore, BS, Karen DeVore, MD   +2 more
doaj   +1 more source